Insider holders · CIK 0001880438
AN2 Therapeutics, Inc. · ANTX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Robin Shane ReadnourDirector | 9,077 | 624,765 | 633,842 | Sep 11, 2026 · 7:45 pm EDT | Form 4 |
| Kabeer AzizDirector | 59,106 | 377,542 | 436,648 | Jul 10, 2026 · 7:41 pm EDT | Form 4 |
| Joshua M EizenSee Remarks | 206,554 | — | 206,554 | Jul 10, 2026 · 6:15 pm EDT | Form 4 |
| Joseph S ZakrzewskiDirector | 145,538 | 0 | 145,538 | Aug 14, 2026 · 2:12 pm EDT | Form 4 |
| Cameron C. Trenor IIIChief Medical Officer | 116,667 | — | 116,667 | Sep 16, 2026 · 5:35 pm EDT | Form 4 |
| Gilbert Lynn MarksDirector | 81,873 | — | 81,873 | Jul 10, 2026 · 7:41 pm EDT | Form 4 |
| Sarah Joanne WilliamsPrincipal Accounting Officer | 66,311 | — | 66,311 | Sep 4, 2026 · 4:25 pm EDT | Form 4 |
| Patricia A. MartinDirector | 18,863 | — | 18,863 | Jul 10, 2026 · 7:40 pm EDT | Form 4 |
| Margaret M FitzPatrickDirector | 10,708 | — | 10,708 | Sep 2, 2026 · 6:43 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.